JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 25 October 2004. doi:10.1083/jcb.200404076
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 167, Number 2, 365-375
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1671K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colognato, H.
Right arrow Articles by ffrench-Constant, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colognato, H.
Right arrow Articles by ffrench-Constant, C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development



Holly Colognato1,2, Shwetha Ramachandrappa1,2, Inger M. Olsen1,2, and Charles ffrench-Constant1,2,3

1 Department of Pathology, University of Cambridge, Cambridge CB21QP, England, UK
2 Centre for Brain Repair, University of Cambridge, Cambridge CB21QP, England, UK
3 Department of Medical Genetics, University of Cambridge, Cambridge CB21QP, England, UK

Correspondence to Holly Colognato: colognato{at}pharm.sunysb.edu

Specific integrins expressed on oligodendrocytes, the myelin-forming cells of the central nervous system, promote either differentiation and survival or proliferation by amplification of growth factor signaling. Here, we report that the Src family kinases (SFKs) Fyn and Lyn regulate each of these distinct integrin-driven behaviors. Fyn associates with {alpha}6ß1 and is required to amplify platelet-derived growth factor survival signaling, to promote myelin membrane formation, and to switch neuregulin signaling from a phosphatidylinositol 3-kinase to a mitogen-activated protein kinase pathway (thereby changing the response from proliferation to differentiation). However, earlier in the lineage Lyn, not Fyn, is required to drive {alpha}Vß3-dependent progenitor proliferation. The two SFKs respond to integrin ligation by different mechanisms: Lyn, by increased autophosphorylation of a catalytic tyrosine; and Fyn, by reduced Csk phosphorylation of the inhibitory COOH-terminal tyrosine. These findings illustrate how different SFKs can act as effectors for specific cell responses during development within a single cell lineage, and, furthermore, provide a molecular mechanism to explain similar region-specific hypomyelination in laminin- and Fyn-deficient mice.

H. Colognato's present address is Dept. of Pharmacology, State University of New York at Stony Brook, Stony Brook, NY 11794.

Abbreviations used in this paper: Csk, COOH-terminal Src kinase; ERK, extracellular signal–related kinase; FN, fibronectin; GalC, galactocerebroside; Lm2, laminin-2; MAG, myelin-associated glycoprotein; MBP, myelin basic protein; NRG, neuregulin; PDGF{alpha}R, PDGF{alpha} receptor; PDL, poly-D-lysine; SFK, Src family kinase; siRNA, small interfering RNA.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents